Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Offers Common Stock; Hopes to Raise $12.6M

NEW YORK, April 23 (GenomeWeb News) - Bruker BioSciences hopes to raise $12.6 million in net proceeds from a public offering of 3 million shares of its common stock, the company said today.

 

The offering coincides with the sale of 12 million shares by four stockholders related to CEO Frank Laukien to the public, which is expected to generate $50.5 million in net proceeds.

 

The stock will be priced at $4.50 per share.

 

Bruker said it plans to use the proceeds for general corporate purposes, potential acquisitions, and possibly for the repayment of debt.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.